Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-121881)

Filing Details

Accession Number:: 0001104659-16-121881
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-18 16:31:34
Reporting Period:: 2016-05-16

Filing Date:: 2016-05-18
Accepted Time:: 2016-05-18 16:31:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660719	Aralez Pharmaceuticals Inc.	ARLZ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1441461	A Mark Glickman	C/O Aralez Pharmaceuticals Inc., 151 Steeles Avenue East Milton A6 L9T 1Y1	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, Without Par Value	Acquisiton	2016-05-16	25,000	$3.68	186,553	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $3.64 to $3.72, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.